KIMBERLI BRAWNER: Open Payments
NPI 1487928842 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$381 in 5 payments from 4 companies in 2025. Trend: 2023 $328 · 2024 $289 · 2025 $381
Food & beverage: $381
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $133 |
| Dexcom, Inc. | 1 | $116 |
| Novo Nordisk Inc | 1 | $105 |
| Tandem Diabetes Care, Inc. | 2 | $27 |
Products named: FREESTYLE LIBRE 3, DEXCOM G7 GSS (161), Ozempic, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across PA — which companies pay providers there.
